NEXT

Latest Stories

August 07, 2012 | Law.com

Circuit Reinstates Bank's Third-Party Investor Claims

A federal appeals court has reinstated a lawsuit in which a German bank seeks to recover at least $60 million in losses that allegedly resulted from Aladdin Capital Management's "grossly negligent" oversight of a collateralized debt obligation.
4 minute read
April 16, 2012 | New York Law Journal

Timing of Expert Disclosure: A Moving Target

6 minute read
June 22, 2005 | New York Law Journal

Real Estate Marketplace

Sports fans will soon be able to get their year-round fix at the nation's first ever National Sports Museum, scheduled to open in Lower Manhattan in 2006.
3 minute read
June 28, 2002 | New York Law Journal

Errors by Judge and Counsel Upset Manslaughter Verdict

Citing an error by the trial judge and an ineffective defense attorney, an appellate court has vacated a manslaughter conviction against a man who shot and killed a bystander during a strip club brawl.
4 minute read
August 28, 2013 | New York Law Journal

Panel Says Police Action Failed to Meet 'DeBour' Standard

In the latest foray into the minefield of police-citizen encounters, a deeply divided Manhattan appellate panel held Tuesday that the presence of a suspicious-looking man in a crime-ridden public housing building did not give police a right to question the individual.
7 minute read
April 12, 2011 | New York Law Journal

Whether Police Had Duty to Keep Woman Safe Is an Issue for Jury

6 minute read
April 10, 2002 | New York Law Journal

Eastern District Roundup

T his column reports on several significant, representative decisions handed down recently in the U.S. District Court for the Eastern District of New York.
11 minute read
December 27, 2005 | New York Law Journal

'Integra': A Fatal Blow to Biotechnology?

David A. Kalow and Milton Springut, partners at Kalow & Springut LLP, write that the Supreme Court, in Merck KGaA v. Integra Lifesciences I, Ltd., has expanded the scope of the Hatch-Waxman Act to protect big pharmaceutical companies from patent infringement suits by smaller biotechnology companies which depend on licensing revenues from research tool patents to survive.
10 minute read
March 19, 2007 | New York Law Journal

New York Practice

Thomas F. Gleason, a member of Gleason, Dunn, Walsh & O'Shea and an adjunct professor at Albany Law School, writes that among the more interesting current issues in New York Practice is when changes can be wrought by uniform rule without the need of legislation.
11 minute read
October 14, 2004 | New York Law Journal

Judge Rejects Claim to Lien on Client Materials

3 minute read

More from ALM

More from ALM

Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.